← golden set
AAPL
Apple Inc.Technologyanswer key
| field | SEC value | XBRL concept | printed on |
|---|---|---|---|
| Total revenue | $416.2B | RevenueFromContractWithCustomerExcludingAssessedTax | Total net sales |
| Operating income | $133.1B | OperatingIncomeLoss | Operating income |
| Net income attributable to the company | $112.0B | NetIncomeLoss | Net income |
| Diluted EPS | $7.46 | EarningsPerShareDiluted | Diluted |
| Cash and cash equivalents | $35.9B | CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents |
| Total assets | $359.2B | Assets | Total assets · Total liabilities and shareholders’ equity |
| Total liabilities | $285.5B | Liabilities | Total liabilities |
| Total shareholders' equity attributable to the company | $73.7B | StockholdersEquity | Total shareholders’ equity |
| Net cash from operating activities | $111.5B | NetCashProvidedByUsedInOperatingActivities | Cash generated by operating activities |
| Net cash from investing activities | $15.2B | NetCashProvidedByUsedInInvestingActivities | Cash generated by investing activities |
| Net cash from financing activities | -$120.7B | NetCashProvidedByUsedInFinancingActivities | Cash used in financing activities |
Income statement
table #14 · score 49.8 vs 24.3 runner-up · in millions| Years ended | |||
| September 27,2025 | September 28,2024 | September 30,2023 | |
| Net sales: | |||
| Products | 307,003 | 294,866 | 298,085 |
| Services | 109,158 | 96,169 | 85,200 |
| Total net sales | 416,161 | 391,035 | 383,285 |
| Cost of sales: | |||
| Products | 194,116 | 185,233 | 189,282 |
| Services | 26,844 | 25,119 | 24,855 |
| Total cost of sales | 220,960 | 210,352 | 214,137 |
| Gross margin | 195,201 | 180,683 | 169,148 |
| Operating expenses: | |||
| Research and development | 34,550 | 31,370 | 29,915 |
| Selling, general and administrative | 27,601 | 26,097 | 24,932 |
| Total operating expenses | 62,151 | 57,467 | 54,847 |
| Operating income | 133,050 | 123,216 | 114,301 |
| Other income/(expense), net | (321) | 269 | (565) |
| Income before provision for income taxes | 132,729 | 123,485 | 113,736 |
| Provision for income taxes | 20,719 | 29,749 | 16,741 |
| Net income | 112,010 | 93,736 | 96,995 |
| Earnings per share: | |||
| Basic | 7.49 | 6.11 | 6.16 |
| Diluted | 7.46 | 6.08 | 6.13 |
| Shares used in computing earnings per share: | |||
| Basic | 14,948,500 | 15,343,783 | 15,744,231 |
| Diluted | 15,004,697 | 15,408,095 | 15,812,547 |
Balance sheet
table #16 · score 51.8 vs 14.3 runner-up · in millions| September 27,2025 | September 28,2024 | |
| ASSETS: | ||
| Current assets: | ||
| Cash and cash equivalents | 35,934 | 29,943 |
| Marketable securities | 18,763 | 35,228 |
| Accounts receivable, net | 39,777 | 33,410 |
| Vendor non-trade receivables | 33,180 | 32,833 |
| Inventories | 5,718 | 7,286 |
| Other current assets | 14,585 | 14,287 |
| Total current assets | 147,957 | 152,987 |
| Non-current assets: | ||
| Marketable securities | 77,723 | 91,479 |
| Property, plant and equipment, net | 49,834 | 45,680 |
| Other non-current assets | 83,727 | 74,834 |
| Total non-current assets | 211,284 | 211,993 |
| Total assets | 359,241 | 364,980 |
| LIABILITIES AND SHAREHOLDERS’ EQUITY: | ||
| Current liabilities: | ||
| Accounts payable | 69,860 | 68,960 |
| Other current liabilities | 66,387 | 78,304 |
| Deferred revenue | 9,055 | 8,249 |
| Commercial paper | 7,979 | 9,967 |
| Term debt | 12,350 | 10,912 |
| Total current liabilities | 165,631 | 176,392 |
| Non-current liabilities: | ||
| Term debt | 78,328 | 85,750 |
| Other non-current liabilities | 41,549 | 45,888 |
| Total non-current liabilities | 119,877 | 131,638 |
| Total liabilities | 285,508 | 308,030 |
| Commitments and contingencies | ||
| Shareholders’ equity: | ||
| Common stock and additional paid-in capital, $0.00001 par value: 50,400,000 shares authorized; 14,773,260 and 15,116,786 shares issued and outstanding, respectively | 93,568 | 83,276 |
| Accumulated deficit | (14,264) | (19,154) |
| Accumulated other comprehensive loss | (5,571) | (7,172) |
| Total shareholders’ equity | 73,733 | 56,950 |
| Total liabilities and shareholders’ equity | 359,241 | 364,980 |
Cash flow statement
table #18 · score 52.3 vs 6.8 runner-up · in millions| Years ended | |||
| September 27,2025 | September 28,2024 | September 30,2023 | |
| Cash, cash equivalents, and restricted cash and cash equivalents, beginning balances | 29,943 | 30,737 | 24,977 |
| Operating activities: | |||
| Net income | 112,010 | 93,736 | 96,995 |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
| Depreciation and amortization | 11,698 | 11,445 | 11,519 |
| Share-based compensation expense | 12,863 | 11,688 | 10,833 |
| Other | (89) | (2,266) | (2,227) |
| Changes in operating assets and liabilities: | |||
| Accounts receivable, net | (6,682) | (3,788) | (1,688) |
| Vendor non-trade receivables | (347) | (1,356) | 1,271 |
| Inventories | 1,400 | (1,046) | (1,618) |
| Other current and non-current assets | (9,197) | (11,731) | (5,684) |
| Accounts payable | 902 | 6,020 | (1,889) |
| Other current and non-current liabilities | (11,076) | 15,552 | 3,031 |
| Cash generated by operating activities | 111,482 | 118,254 | 110,543 |
| Investing activities: | |||
| Purchases of marketable securities | (24,407) | (48,656) | (29,513) |
| Proceeds from maturities of marketable securities | 40,907 | 51,211 | 39,686 |
| Proceeds from sales of marketable securities | 12,890 | 11,135 | 5,828 |
| Payments for acquisition of property, plant and equipment | (12,715) | (9,447) | (10,959) |
| Other | (1,480) | (1,308) | (1,337) |
| Cash generated by investing activities | 15,195 | 2,935 | 3,705 |
| Financing activities: | |||
| Payments for taxes related to net share settlement of equity awards | (5,960) | (5,441) | (5,431) |
| Payments for dividends and dividend equivalents | (15,421) | (15,234) | (15,025) |
| Repurchases of common stock | (90,711) | (94,949) | (77,550) |
| Proceeds from issuance of term debt, net | 4,481 | - | 5,228 |
| Repayments of term debt | (10,932) | (9,958) | (11,151) |
| Proceeds from/(Repayments of) commercial paper, net | (2,032) | 3,960 | (3,978) |
| Other | (111) | (361) | (581) |
| Cash used in financing activities | (120,686) | (121,983) | (108,488) |
| Increase/(Decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 5,991 | (794) | 5,760 |
| Cash, cash equivalents, and restricted cash and cash equivalents, ending balances | 35,934 | 29,943 | 30,737 |
| Supplemental cash flow disclosure: | |||
| Cash paid for income taxes, net | 43,369 | 26,102 | 18,679 |